In this podcast Dan Housman and Joy Alamgir discuss the importance and value of commercial:public collaborations that leverage real-time real world data to accelerate COVID-19 research efforts. Currently there is a limited understanding of the potential efficacy of existing therapies to treat and manage COVID-19. Opportunities to investigate research into the repurposing of existing therapies may be both clinically and cost effective.